Sopharma AD-Sofia (FRA:3JR) Total Liabilities : €394.5 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Sopharma AD-Sofia Total Liabilities?

Sopharma AD-Sofia's Total Liabilities for the quarter that ended in Dec. 2023 was €394.5 Mil.

Sopharma AD-Sofia's quarterly Total Liabilities increased from Jun. 2023 (€330.79 Mil) to Sep. 2023 (€367.37 Mil) and increased from Sep. 2023 (€367.37 Mil) to Dec. 2023 (€394.53 Mil).

Sopharma AD-Sofia's annual Total Liabilities declined from Dec. 2021 (€283.29 Mil) to Dec. 2022 (€278.75 Mil) but then increased from Dec. 2022 (€278.75 Mil) to Dec. 2023 (€394.53 Mil).

Sopharma AD-Sofia Total Liabilities Historical Data

The historical data trend for Sopharma AD-Sofia's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia Total Liabilities Chart

Sopharma AD-Sofia Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

310.99

350.42

283.29

278.75

394.53

Sopharma AD-Sofia Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial															278.75	291.57	330.79	367.37	394.53

Sopharma AD-Sofia Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sopharma AD-Sofia's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	316.016	+	(57.68	+	16.497
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	4.333)
	=	394.5

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	785.467	-	390.941
	=	394.5

Sopharma AD-Sofia's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	316.016	+	(57.68	+	16.497
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	4.333)
	=	394.5

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	785.467	-	390.941
	=	394.5

Sopharma AD-Sofia Total Liabilities Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma AD-Sofia (FRA:3JR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (FRA:3JR) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

SPH:Poland SFA:Bulgaria

Address

5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756

Website

https://www.sopharmagroup.com

Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are organized based on the production of finished products which include Tablet dosage forms, Ampoule dosage forms, Medical products, Other forms, and Other revenue. Geographically company operates in Bulgaria and internationally.

Sopharma AD-Sofia (FRA:3JR) Headlines

No Headlines